Curaleaf Holdings (CURLF) Change in Account Payables (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Change in Account Payables of -$10.0 million for Q4 2024, down 153.26% year-over-year from $18.7 million in Q1 2024, and up 20.19% quarter-over-quarter from -$12.5 million in Q3 2024.
Curaleaf Holdings (CURLF) Change in Account Payables (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Change in Account Payables history runs 6 years deep, the most recent figure standing at -$10.0 million for Q4 2024.
- In Q4 2024, Change in Account Payables fell 153.26% year-over-year to -$10.0 million; the TTM figure through Dec 2024 stood at -$18.6 million (down 218.68% YoY), while the FY2025 annual figure was -$5.2 million, up 7.76% from the prior year.
- Change in Account Payables for Q4 2024 stood at -$10.0 million, up from -$12.5 million in the prior quarter.
- The five-year high for Change in Account Payables was $35.8 million in Q1 2022, with the low at -$14.9 million in Q3 2023.
- The 5-year median for Change in Account Payables is $586000.0 (2021), against an average of $1.9 million.
- The sharpest annual moves came in 2022 and 2023: Change in Account Payables surged 12179.39% in 2022, then sank 242.59% in 2023.
- Curaleaf Holdings' Change in Account Payables stood at $15.2 million in 2020, then plunged by 155.18% to -$8.4 million in 2021, then soared by 117.47% to $1.5 million in 2022, then surged by 1173.02% to $18.7 million in 2023, then slumped by 153.26% to -$10.0 million in 2024.
- Business Quant data shows CURLF's Change in Account Payables at -$10.0 million in Q4 2024, -$12.5 million in Q3 2024, and $18.7 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Curaleaf Holdings | 2.49 Bn | 2.39 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -9.95 Mn |
| Dec 31, 2024 | -9.95 Mn |
| Sep 30, 2024 | -12.47 Mn |
| Sep 30, 2024 | -12.47 Mn |
| Dec 31, 2023 | 18.69 Mn |
| Dec 31, 2023 | 18.69 Mn |
| Sep 30, 2023 | -14.90 Mn |
| Sep 30, 2023 | -14.90 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 10.45 Mn |
| Sep 30, 2022 | 10.45 Mn |
| Jun 30, 2022 | 2.42 Mn |
| Jun 30, 2022 | 2.42 Mn |
| Mar 31, 2022 | 35.76 Mn |
| Mar 31, 2022 | 35.76 Mn |
| Dec 31, 2021 | -8.40 Mn |
| Dec 31, 2021 | -8.40 Mn |
| Sep 30, 2021 | 2.62 Mn |
| Sep 30, 2021 | 2.62 Mn |